Neuromuscular disorders in childhood: The time for palliative cares?;Les maladies neuromusculaires chez l'enfant: Place et définition des soins palliatifs?

Medecine Palliative

Volumn 9, Issue 6, 2010, Pages 291-296

  Desguerre, Isabelle ^a   Barnerias, Christine ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Arthrodesis; Child; Duchenne; Neuromuscular disorders; Pain; Spinal motor atrophy; Standard care

Indexed keywords

EID: 78649907875     PISSN: 16366522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medpal.2010.09.006     Document Type: Article

References (17)

1. Roper H, Quinlivan R, on behalf of workshop participants. Implementation of " The consensus statement for the standard of care in spinal muscular atrophy" when applied to infants with severe type 1 SMA in the UK. Arch Dis Child 2010;95(10):845-49.
2. Wang C.H., Finkel R.S., Bertini E.S., Schroth M., Simonds A., Wong B., et al. Participants of the international conference on SMA standard of care consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007, 22:1027-1049.
3. Darin N., Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000, 10:1-9.
4. Van Essen AJ, Verheij JBGM, Reefhuis J, et al. The natural history of Duchenne muscular dystrophy: analysis of data from a Dutch survey and review of age-related events. Leyden muscular dystrophy data base. 2004.
5. Brooke M.H., Fenichel G.M., Griggs R.C., Mendell J.R., Moxley R., Florence J., et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 1989, 39:475-481.
6. Brooke M.H., Fenichel G.M., Griggs R., Schumate J.B., Pellegrino R.J. Clinical investigation in Duchenne dystrophy: determination of the power of therapeutic trials based on natural history. Muscle Nerve 1983, 6:91-103.
7. Desguerre I., Christo C., Mayer M., et al. Phenotypic heterogeneity of Duchenne muscular dystrophy assessed by long-term follow-up: identification of indicators predicting future outcome. PLoSOne 2009, 4.
8. Bakker J.P., de Groot I.J., Beckerman H., De Jong B.A., Lankhorst G.J. The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clin Rehabil 2000, 14:343-359.
9. Eagle M., Bourke J., Bullock R., Gibson M., Struab V., et al. Managing Duchenne muscular dystrophy.The additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 2007, 17:470-475.
10. Duboc D., Meune C., Pierre B., et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007, 154:596-602.
11. Jeppesen J., Green A., Steffensen B.F., Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003, 13:804-812.
12. Toussaint M., Steens M., Soudon P. Lung function accurately predicts hypercapnia in patients with Duchenne muscular dystrophy. Chest 2007, 131:368-375.
13. Bach J.R., Ishikawa Y., Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997, 112:1024-1028.
14. Willig T.N., Carlier L., Legrand M., Rivière H., Navarro J. Nutritional assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 1993, 35:1074-1082.
15. Cotton S., Vodaris N.J., Greenwood K.M. Intelligence and Duchenne muscular dystrophy. Full scale, verbal and performance intelligence quotients. Dev Med Child Neurol 2001, 43:497-501.
16. Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., et al. DMD Care considerations working group diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010, 9:177-189.
17. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008; CD003725. Review.